Agentic bioinformatics treats biomedical discovery as a closed-loop system where specialized AI agents continuously translate intent into computation, computation into evidence, and evidence into the next experiment.
Serum proteomics exposes how sepsis and hemophagocytic syndromes diverge at the level of immune regulation and proteostasis, enabling precise molecular discrimination.
MRD detection in breast cancer focuses on uncovering functional transcriptomic and microenvironmental signals that reveal persistent tumor activity invisible to traditional genomic approaches.
Multi-omics and principled transfer learning transform checkpoint therapy from empirical trial-and-error into model-guided, patient-specific decision-making.
AlphaFold 3 turns sequences and chemotypes into atom-wise structural ensembles that make mechanism and design a single, accelerated workflow rather than a stitched pipeline.
AutoML systematizes model and pipeline selection for omics and GWAS, making nonlinear signals and multi-objective priorities tractable without sacrificing interpretability.
By treating spatial transcriptomics as a language of tissue architecture, SIGEL learns gene embeddings that make downstream spatial genomics both tractable and biologically faithful.
Pediatric eosinophilic esophagitis expresses a conserved esophageal molecular program that can be read in blood through integrative panels combining cytokines, immunoglobulins, and B-vitamer–linked metabolites.
The dark genome is not a biological void but a frontier awaiting illumination.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings